TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner
Molecular Therapy · 2025
DOI: 10.1016/j.ymthe.2025.01.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Honglei Kang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Research Ins…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Oxidative Phosphorylation, Osteogenesis, Osteoclasts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Tongji Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor necrosis factor receptor-associated factor 1 (TRAF1) is a crucial signaling adaptor involved in multiple cellular events. However, its role in regulating osteoclastogenesis and energy metabolism remains unclear. Here, we report that TRAF1 promotes osteoclastogenesis and oxidative phosphorylation (OXPHOS). Employing RNA sequencing, we found that TRAF1 is markedly upregulated during osteoclastogenesis and is positively associated with osteoporosis. TRAF1 knockout inhibits osteoclastogenesis and increases bone mass in both normal and ovariectomized adult mice without affecting bone mass in childhood. Furthermore, TRAF1 promotes osteoclast OXPHOS by increasing the phosphorylation level of AKT. Mechanistically, TRAF1 functions to inhibit TRAF2-induced ubiquitination of Gβl, a known activator of AKT, and further upregulates AKT phosphorylation. Rescue experiments revealed that the inhibitory effects of TRAF1 knockout on osteoclastogenesis, OXPHOS, and bone mass are dependent on AKT. Collectively, our findings uncover a previously unrecognized function of TRAF1 in regulating osteoclastogenesis and energy metabolism, and establish a novel TRAF1-AKT-OXPHOS axis in osteoclasts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Research Institute of Shenzhen Huazhong University of Science and Technology, Shen…
- Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, China.
- Department of Orthopedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, China. Electronic address: zhemingliu@whu.edu.cn.
- Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, China. E…
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Tongji Hospital
- National Natural Science Foundation of China
Zitieren
APA
Kang, H., Peng, R., Dong, Y., Liao, F., Zhu, M., Wang, P., Hu, S. A., Hu, P., Wang, J., Liu, Z., Song, K., & Li, F. (2025). TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.01.040
Vancouver
Kang H, Peng R, Dong Y, Liao F, Zhu M, Wang P, et al. TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.01.040
BibTeX
@article{Kang2025,
author = {Kang, Honglei and Peng, Renpeng and Dong, Yimin and Liao, Fuben and Zhu, Meipeng and Wang, Pengju and Hu, Shi-An and Hu, Peixuan and Wang, Jia and Liu, Zheming and Song, Kehan and Li, Feng},
title = {TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner},
journal = {Molecular Therapy},
year = {2025},
doi = {10.1016/j.ymthe.2025.01.040}
}
EUVIMED